Developer docs
API playgroundTry for free, no card

Search company profiles

Dow Development Laboratories

Full company profile

uuid000drlf

Namestring
Dow Development Laboratories
Legal namestring
Dow Development Laboratories, LLC
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Dow Development Laboratories (DDL) is a specialty contract development and manufacturing organization (CDMO) focused on topical pharmaceutical drug products. Founded in 2013 and headquartered in a 23,000-square-foot custom-built facility in Petaluma, California, the company provides formulation design, analytical method development and validation, GMP manufacturing of clinical supplies, clinical packaging and labeling, and CMC documentation support. DDL specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, and suspensions, and has expanded into ophthalmic product development. The company is FDA-registered and operates under cGMP and GLP quality standards, with batch capabilities spanning 1 kg laboratory scale up to over 1,000 kg commercial scale.

Technically, DDL leverages deep expertise in formulation chemistry including solubility enhancement, excipient compatibility, preservation systems, lipid-based systems, nanotechnology, microneedles, encapsulation technologies, and proprietary silicone-based microemulsion systems. The firm also conducts research on critical material attributes of compendial raw materials and their impact on drug product viscosity, degradation, and appearance. A flagship commercial outcome was DDL's end-to-end support of Arcutis Biotherapeutics' Zoryve (roflumilast) cream 0.3% from inception through FDA approval in 2022.

DDL generates revenue on a fee-for-service, project-based model, selling directly to pharmaceutical and biotech company sponsors through sales-led business development with dedicated project managers and technical team leaders. Its go-to-market is reinforced by thought-leadership content (FormulationForum blog, resources library, Dow Development Institute) and scientific poster presentations at conferences such as AAPS PharmSci360. DDL operates as a subsidiary of Symbio, a diversified R&D group, and serves clients globally from its single Northern California facility.

Short descriptiontext

Dow Development Laboratories is a specialty CDMO providing formulation development, analytical testing, GMP manufacturing, and clinical packaging for topical and ophthalmic pharmaceutical drug products, serving pharmaceutical and biotech sponsors from its FDA-registered, cGMP-compliant facility in Petaluma, California.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPetaluma, United States
HQ citystring
Petaluma
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
topical pharmaceutical development, contract manufacturing organization, drug formulation services, clinical supplies manufacturing, analytical method development
Industry3 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Contract Development and Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Pharmaceutical Development Services
TypeProfessional Services
Description

DDL generates revenue through providing fee-for-service contract development and manufacturing services to pharmaceutical and biotech companies. Services include formulation development, analytical method development, GMP manufacturing, clinical packaging and labeling, and regulatory support. Revenue is project-based with contracts typically spanning development programs from inception through regulatory approval.

dowdevelopmentlabs.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Dow Development Laboratories is a specialty contract development and manufacturing organization (CDMO) that provides topical pharmaceutical drug product formulation, development, manufacturing, testing, packaging, and labeling services to pharmaceutical and biotech companies. The company specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, suspensions, and pastes, supporting clients from formulation inception through FDA approval. Operations are conducted at an FDA-registered, cGMP-compliant 23,000 square foot facility in Petaluma, California.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Successful FDA approval of Zoryve (roflumilast) cream 0.3% for plaque psoriasis in 2022
Product overview1 text field

Dow Development Laboratories (DDL) is a specialty contract development and manufacturing organization (CDMO) providing comprehensive services for topical pharmaceutical drug product development. The company operates as a single unified offering combining formulation design, analytical methods development, manufacturing, and clinical packaging services. The core portfolio includes Topical Formulation Design and Development, Topical Drug Product Testing with Methods & Stability Studies, Ophthalmic Product Development, Drug Product Manufacturing, and Clinical Packaging & Labeling. These services are complemented by CMC Documentation Support and the Dow Development Institute educational arm. The company specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, and pastes for various therapeutic indications.

Product and service6 records
1Topical Formulation Design and Development
CategoryContract Pharmaceutical Development
Description

Contract formulation development services for semi-solid and liquid topical drug products including gels, creams, ointments, solutions, sprays, and suspensions for dermatologic, ophthalmic, women's and men's health, pain, wound healing, and infection indications. Includes solubility studies, excipient compatibility studies, prototype formulation design, and lead formulation selection for IND-enabling studies under GLP.

2Topical Drug Product Testing, Methods & Stability Studies
CategoryPharmaceutical Testing Services
Description

Comprehensive analytical and quality testing services for topical pharmaceutical products including analytical method development and validation (HPLC assay methods for preserved formulations), ICH stability studies, packaging compatibility testing, and quality control testing.

3Ophthalmic Product Development
CategoryContract Pharmaceutical Development
Description

Specialized contract development services for ophthalmic drug products requiring fundamentally different analytical and formulation approaches from semi-solid dosage form development.

4Drug Product Manufacturing (Clinical Supplies)
CategoryContract Manufacturing (CDMO)
Description

R&D, GLP, and GMP contract manufacturing and filling of topical drug products including gels, creams, ointments, solutions, sprays, and pastes for clinical trial supplies, with batch capacity up to 40 kilograms and scale-up capabilities from 1 kg to over 1,000 kg.

5Clinical Packaging & Labeling
CategoryClinical Supply Services
Description

GMP clinical supplies packaging, labeling, and distribution services for pharmaceutical products entering clinical trials.

6CMC Documentation Support & Product Development Consulting
CategoryPharmaceutical Consulting
Description

Consulting services for clients new to topical drug development, including regulatory guidance, CMC documentation support, and decision-making support across the development program.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierParent CompanyTypeOthers
Description

Symbio is the parent company of Dow Development Laboratories (DDL). DDL operates as a subsidiary of Symbio, leveraging the parent company's resources and infrastructure while maintaining specialized focus on topical pharmaceutical development.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Tapemark
TypeDirect peer
Description

Tapemark is a specialty CDMO focused on topical and transdermal drug product development and manufacturing, including formulation, scale-up, and clinical/commercial supply. Highly comparable to DDL given the shared topical semi-solid and liquid dosage form specialization and similar SMB CDMO positioning.

TypeBroad incumbent
Description

Hovione is a CDMO specializing in oral, inhaled, and topical drug product development and manufacturing, with semi-solid and cream formulation capabilities. Comparable to DDL via shared topical formulation services, though Hovione operates globally with substantially broader capacity.

TypeDirect peer
Description

Tergus Pharma is a niche CDMO specializing in semi-solid and liquid topical pharmaceutical development, including formulation, analytical, and GMP manufacturing services. Directly comparable to DDL's core service portfolio in gels, creams, and ointments for dermatology and adjacent indications.

TypeBroad incumbent
Description

PCI Pharma Services is a global CDMO offering formulation development, clinical and commercial manufacturing, and packaging services across sterile and non-sterile dosage forms including topicals. Comparable to DDL's CDMO service model, though PCI operates at significantly larger scale and modality breadth.

TypeBroad incumbent
Description

Thermo Fisher's Patheon business is a global CDMO providing formulation, analytical, and commercial manufacturing across multiple dosage forms including topical semi-solids. Comparable to DDL as a CDMO serving pharma and biotech, though operates at much greater scale and modality breadth.

TypeRegional player
Description

Pillar5 Pharma is a Canadian CDMO offering semi-solid and liquid topical pharmaceutical manufacturing, including creams, ointments, and gels for clinical and commercial supply. Comparable to DDL's topical CDMO focus and SMB scale, but operates primarily in North America from a single non-US facility.

TypeDirect peer
Description

Halo Pharma is a CDMO offering formulation, development, and manufacturing for semi-solid and liquid topical dosage forms, including clinical and commercial supply. Comparable to DDL through shared topical CDMO positioning and pharmaceutical client base.

8Velesco Pharma
TypeEmerging player
Description

Velesco Pharma is a small CDMO providing early-phase formulation development and cGMP manufacturing for liquids, creams, and ointments. Comparable to DDL in early-development topical services and as a nimble specialty CDMO targeting biotech clients.

TypeBroad incumbent
Description

Catalent (now owned by Novo Holdings) is a global full-service CDMO offering topical, oral, and injectable drug product development and manufacturing at commercial scale. Comparable to DDL via its topical and semi-solid dose capabilities, but much larger and broader in modality.

TypeRegional player
Description

Groupe Parima is a Canadian CDMO specializing in semi-solid and liquid topical pharmaceutical development and manufacturing, including formulation, GMP manufacturing, and packaging. Comparable to DDL through topical CDMO services and SMB scale, with primary Canadian/regional presence.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dow Development Laboratories

Pharmaceutical Contract Development and Manufacturingdowdevelopmentlabs.com

Dow Development Laboratories is a specialty CDMO providing formulation development, analytical testing, GMP manufacturing, and clinical packaging for topical and ophthalmic pharmaceutical drug products, serving pharmaceutical and biotech sponsors from its FDA-registered, cGMP-compliant facility in Petaluma, California.

What Dow Development Laboratories does

Dow Development Laboratories (DDL) is a specialty contract development and manufacturing organization (CDMO) focused on topical pharmaceutical drug products. Founded in 2013 and headquartered in a 23,000-square-foot custom-built facility in Petaluma, California, the company provides formulation design, analytical method development and validation, GMP manufacturing of clinical supplies, clinical packaging and labeling, and CMC documentation support. DDL specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, and suspensions, and has expanded into ophthalmic product development. The company is FDA-registered and operates under cGMP and GLP quality standards, with batch capabilities spanning 1 kg laboratory scale up to over 1,000 kg commercial scale.

Technically, DDL leverages deep expertise in formulation chemistry including solubility enhancement, excipient compatibility, preservation systems, lipid-based systems, nanotechnology, microneedles, encapsulation technologies, and proprietary silicone-based microemulsion systems. The firm also conducts research on critical material attributes of compendial raw materials and their impact on drug product viscosity, degradation, and appearance. A flagship commercial outcome was DDL's end-to-end support of Arcutis Biotherapeutics' Zoryve (roflumilast) cream 0.3% from inception through FDA approval in 2022.

DDL generates revenue on a fee-for-service, project-based model, selling directly to pharmaceutical and biotech company sponsors through sales-led business development with dedicated project managers and technical team leaders. Its go-to-market is reinforced by thought-leadership content (FormulationForum blog, resources library, Dow Development Institute) and scientific poster presentations at conferences such as AAPS PharmSci360. DDL operates as a subsidiary of Symbio, a diversified R&D group, and serves clients globally from its single Northern California facility.

Dow Development Laboratories firmographics

Firmographics
Name
Dow Development Laboratories
Legal name
Dow Development Laboratories, LLC
Website
https://dowdevelopmentlabs.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Dow Development Laboratories is a specialty CDMO providing formulation development, analytical testing, GMP manufacturing, and clinical packaging for topical and ophthalmic pharmaceutical drug products, serving pharmaceutical and biotech sponsors from its FDA-registered, cGMP-compliant facility in Petaluma, California.
Ownership category
akta.pro rank

Dow Development Laboratories industry classification

Industry
Product category
Pharmaceutical Contract Development and Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Topical pharmaceutical development
  • Contract manufacturing organization
  • Drug formulation services
  • Clinical supplies manufacturing
  • Analytical method development

Where Dow Development Laboratories is headquartered

Location

Headquarters

HQ city
Petaluma
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Dow Development Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Pharmaceutical Development Services: DDL generates revenue through providing fee-for-service contract development and manufacturing services to pharmaceutical and biotech companies. Services include formulation development, analytical method development, GMP manufacturing, clinical packaging and labeling, and regulatory support. Revenue is project-based with contracts typically spanning development programs from inception through regulatory approval.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Dow Development Laboratories product offering

Product offering

Core offering

Dow Development Laboratories is a specialty contract development and manufacturing organization (CDMO) that provides topical pharmaceutical drug product formulation, development, manufacturing, testing, packaging, and labeling services to pharmaceutical and biotech companies. The company specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, suspensions, and pastes, supporting clients from formulation inception through FDA approval. Operations are conducted at an FDA-registered, cGMP-compliant 23,000 square foot facility in Petaluma, California.

Product overview

Dow Development Laboratories (DDL) is a specialty contract development and manufacturing organization (CDMO) providing comprehensive services for topical pharmaceutical drug product development. The company operates as a single unified offering combining formulation design, analytical methods development, manufacturing, and clinical packaging services. The core portfolio includes Topical Formulation Design and Development, Topical Drug Product Testing with Methods & Stability Studies, Ophthalmic Product Development, Drug Product Manufacturing, and Clinical Packaging & Labeling. These services are complemented by CMC Documentation Support and the Dow Development Institute educational arm. The company specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, and pastes for various therapeutic indications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Topical Formulation Design and Development Contract formulation development services for semi-solid and liquid topical drug products including gels, creams, ointments, solutions, sprays, and suspensions for dermatologic, ophthalmic, women's and men's health, pain, wound healing, and infection indications. Includes solubility studies, excipient compatibility studies, prototype formulation design, and lead formulation selection for IND-enabling studies under GLP.
  • Topical Drug Product Testing, Methods & Stability Studies Comprehensive analytical and quality testing services for topical pharmaceutical products including analytical method development and validation (HPLC assay methods for preserved formulations), ICH stability studies, packaging compatibility testing, and quality control testing.
  • Ophthalmic Product Development Specialized contract development services for ophthalmic drug products requiring fundamentally different analytical and formulation approaches from semi-solid dosage form development.
  • Drug Product Manufacturing (Clinical Supplies) R&D, GLP, and GMP contract manufacturing and filling of topical drug products including gels, creams, ointments, solutions, sprays, and pastes for clinical trial supplies, with batch capacity up to 40 kilograms and scale-up capabilities from 1 kg to over 1,000 kg.
  • Clinical Packaging & Labeling GMP clinical supplies packaging, labeling, and distribution services for pharmaceutical products entering clinical trials.
  • CMC Documentation Support & Product Development Consulting Consulting services for clients new to topical drug development, including regulatory guidance, CMC documentation support, and decision-making support across the development program.

Quantifiable outcome

  • Successful FDA approval of Zoryve (roflumilast) cream 0.3% for plaque psoriasis in 2022

Companies that use Dow Development Laboratories

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Dow Development Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Dow Development Laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Symbioparent companyOthersSymbio is the parent company of Dow Development Laboratories (DDL). DDL operates as a subsidiary of Symbio, leveraging the parent company's resources and infrastructure while maintaining specialized focus on topical pharmaceutical development.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Dow Development Laboratories competitors and assessment

Company assessment

Direct peers

  • Tapemark: Tapemark is a specialty CDMO focused on topical and transdermal drug product development and manufacturing, including formulation, scale-up, and clinical/commercial supply. Highly comparable to DDL given the shared topical semi-solid and liquid dosage form specialization and similar SMB CDMO positioning.
  • Tergus Pharma: Tergus Pharma is a niche CDMO specializing in semi-solid and liquid topical pharmaceutical development, including formulation, analytical, and GMP manufacturing services. Directly comparable to DDL's core service portfolio in gels, creams, and ointments for dermatology and adjacent indications.
  • Halo Pharma: Halo Pharma is a CDMO offering formulation, development, and manufacturing for semi-solid and liquid topical dosage forms, including clinical and commercial supply. Comparable to DDL through shared topical CDMO positioning and pharmaceutical client base.

Broad incumbents

  • Hovione: Hovione is a CDMO specializing in oral, inhaled, and topical drug product development and manufacturing, with semi-solid and cream formulation capabilities. Comparable to DDL via shared topical formulation services, though Hovione operates globally with substantially broader capacity.
  • PCI Pharma Services: PCI Pharma Services is a global CDMO offering formulation development, clinical and commercial manufacturing, and packaging services across sterile and non-sterile dosage forms including topicals. Comparable to DDL's CDMO service model, though PCI operates at significantly larger scale and modality breadth.
  • Thermo Fisher Scientific (Patheon): Thermo Fisher's Patheon business is a global CDMO providing formulation, analytical, and commercial manufacturing across multiple dosage forms including topical semi-solids. Comparable to DDL as a CDMO serving pharma and biotech, though operates at much greater scale and modality breadth.
  • Catalent (Novo Holdings): Catalent (now owned by Novo Holdings) is a global full-service CDMO offering topical, oral, and injectable drug product development and manufacturing at commercial scale. Comparable to DDL via its topical and semi-solid dose capabilities, but much larger and broader in modality.

Regional players

  • Pillar5 Pharma: Pillar5 Pharma is a Canadian CDMO offering semi-solid and liquid topical pharmaceutical manufacturing, including creams, ointments, and gels for clinical and commercial supply. Comparable to DDL's topical CDMO focus and SMB scale, but operates primarily in North America from a single non-US facility.
  • Groupe Parima: Groupe Parima is a Canadian CDMO specializing in semi-solid and liquid topical pharmaceutical development and manufacturing, including formulation, GMP manufacturing, and packaging. Comparable to DDL through topical CDMO services and SMB scale, with primary Canadian/regional presence.

Emerging players

  • Velesco Pharma: Velesco Pharma is a small CDMO providing early-phase formulation development and cGMP manufacturing for liquids, creams, and ointments. Comparable to DDL in early-development topical services and as a nimble specialty CDMO targeting biotech clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Dow Development Laboratories compliance and trust

Trust signal

Compliance2 records

Dow Development Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dow Development Laboratories leadership team

Management profile

Number of profiles

Dow Development Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dow Development Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dow Development Laboratories

What does Dow Development Laboratories do?

Dow Development Laboratories is a specialty contract development and manufacturing organization (CDMO) that provides topical pharmaceutical drug product formulation, development, manufacturing, testing, packaging, and labeling services to pharmaceutical and biotech companies. The company specializes in semi-solid and liquid dosage forms including gels, creams, ointments, solutions, sprays, suspensions, and pastes, supporting clients from formulation inception through FDA approval. Operations are conducted at an FDA-registered, cGMP-compliant 23,000 square foot facility in Petaluma, California.

Is Dow Development Laboratories a public or private company?

Dow Development Laboratories is a private company. It is classified as corporate owned and is currently operating.

When was Dow Development Laboratories founded?

Dow Development Laboratories was founded in 2013. It employs 11 to 50 people.

Where is Dow Development Laboratories based?

Dow Development Laboratories is headquartered in Petaluma, United States, in the North America region.

How does Dow Development Laboratories make money?

One revenue line is on record: contract Pharmaceutical Development Services.

Who are Dow Development Laboratories's main competitors?

Direct peers on record are Tapemark, Tergus Pharma and Halo Pharma. Broad incumbents are Hovione, PCI Pharma Services, Thermo Fisher Scientific (Patheon) and Catalent (Novo Holdings). Regional players are Pillar5 Pharma and Groupe Parima. Velesco Pharma is listed as an emerging player.

Does Dow Development Laboratories have an API?

No public API is recorded for Dow Development Laboratories.

What industry is Dow Development Laboratories in?

Dow Development Laboratories's product category is Pharmaceutical Contract Development and Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAL, Process Development & Tech Transfer Services (CDMO). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DowdevelopmentlabsThe Potential of Topical Drug Delivery: Advancements in Dermatological FormulationsThe article outlines recent advancements in topical drug delivery systems for dermatology, highlighting innovations such as nanotechnology, microneedle patches, and specialized vehicles like foams and gels. It emphasizes the role of specialized Contract Development and Manufacturing Organizations (CDMOs) like Dow Development Labs in supporting pharmaceutical companies with formulation, analytical testing, and regulatory strategy. The piece discusses how these technologies improve patient adherence and product performance while navigating complex regulatory requirements.DowdevelopmentlabsInnovative Techniques for Evaluating Topical Formulations: Advancements in Drug Product TestingAn article reviews emerging methods for evaluating topical drug formulations, including mass spectrometry, confocal microscopy and Raman spectroscopy, and artificial intelligence for predicting skin permeability and absorption. It argues that outsourcing testing to specialized laboratories, citing Dow Development Labs, provides access to advanced equipment and expertise.DowdevelopmentlabsThe Advancements in Topical Pharmaceutical Product Development: New Formulation Techniques and IngredientsAn informational piece outlines recent advances in topical pharmaceutical development, covering formulation techniques such as nanotechnology and microencapsulation, and ingredients including plant-based options like aloe vera, tea tree oil and chamomile, plus ceramides and peptides. It promotes outsourcing formulation, method development, packaging, labeling and testing to Dow Development Labs, citing cost and regulatory advantages.DowdevelopmentlabsInnovative Technologies Driving Advancements in Topical Drug Delivery SystemsAn industry article describes how emerging technologies are advancing topical drug delivery systems, citing nanotechnology, microneedles, 3D printing and smart controlled-release devices. It notes challenges such as stability and low bioavailability, and promotes Dow Development Labs' contract development services for formula, method, packaging, labeling and testing. No financial figures or specific product data are disclosed.